Management of fetal growth restriction

Sebastian Illanes1, Peter Soothill

  • 1Fetal Medicine Research Unit, University of Bristol, St Michael's Hospital, Southwell Street, Bristol BS8 4NE, UK.

Insights

Identifying fetuses with placental dysfunction is crucial for improving perinatal outcomes. Timely assessment and intervention for growth-restricted fetuses can reduce risks.

Area of Science:

  • Perinatal medicine
  • Fetal development
  • Obstetrics

Background:

  • Fetal growth restriction (FGR) due to placental dysfunction increases risks for poor perinatal outcomes.
  • Distinguishing pathological FGR from constitutional small size is vital for appropriate management.
  • Current management strategies require refinement for optimal fetal assessment and intervention.

Purpose of the Study:

  • To review and rationalize the assessment methods for fetuses with suspected placental dysfunction.
  • To outline strategies for improving perinatal outcomes through timely intervention.
  • To guide the ideal timing of delivery for at-risk fetuses.

Main Methods:

  • Literature review focusing on fetal growth assessment and placental function.
  • Analysis of diagnostic criteria for identifying placental insufficiency.
  • Evaluation of intervention strategies and timing of delivery.

Main Results:

  • Placental function assessment is key to differentiating pathological FGR from constitutional smallness.
  • Longitudinal monitoring aids in identifying fetuses at high risk.
  • Optimizing the timing of delivery is critical for reducing fetal morbidity and mortality.

Conclusions:

  • Accurate assessment of placental function is essential for managing fetuses with reduced size.
  • Targeted interventions and appropriate timing of delivery can significantly improve perinatal outcomes in FGR.
  • This review provides a framework for rationalizing fetal assessment and management strategies.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...